MRI INFLAMMATION, DISEASE ACTIVITY AND FUNCTIONAL IMPAIRMENT ARE MORE EFFECTIVELY REDUCED BY ESCALATION TO BIOLOGICS COMPARED TO CSDMARD-ESCALATION IN RHEUMATOID ARTHRITIS PATIENTS IN CLINICAL REMISSION FOLLOWING A TREAT-TO-TARGET STRATEGY: SECONDARY ANALYSES OF THE IMAGINE-RA TRIAL

Signe Møller-Bisgaard*, Kim Hørslev-Petersen, Bo Jannik Ejbjerg, Merete Lund Hetland, R. Christensen, Lykke Ornbjerg, D. Glinatsi, J. Møllenbach Møller, M. Boesen, Kristian Stengaard-Pedersen, Ole Rintek Madsen, B. Jensen, J. Villadsen, Ellen Margrethe Hauge, Philip Bennett, Oliver Hendricks, K. Asmussen, M. Kowalski, H.M. Lindegaard, Henning BliddalN. Steen Krogh, Torkell Juulsgaard Ellingsen, A. Nielsen, Anne Grethe Jurik, L. Balding, H. Thomsen, M Østergaard

*Kontaktforfatter for dette arbejde

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

OriginalsprogEngelsk
Publikationsdato6. jun. 2020
StatusUdgivet - 6. jun. 2020
BegivenhedEULAR 2020 - E-Congress
Varighed: 3. jun. 20206. jun. 2020

Konference

KonferenceEULAR 2020
LokationE-Congress
Periode03/06/202006/06/2020

Citationsformater